Minimal Residual Disease in Acute Lymphoblastic Leukemia
2 Bekeken
• 06/15/23
0
0
insluiten
administrator
abonnees
The panelists, Raoul Tibes, MD, PhD; Stefan Faderl, MD; and Bijal D. Shah, MD, outline methods of measuring minimal residual disease and its role in the management of acute lymphoblastic leukemia.
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties